Masimo Co. (NASDAQ:MASI) Shares Sold by Russell Investments Group Ltd.

Russell Investments Group Ltd. lowered its position in shares of Masimo Co. (NASDAQ:MASIGet Rating) by 25.6% during the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 9,408 shares of the medical equipment provider’s stock after selling 3,240 shares during the quarter. Russell Investments Group Ltd.’s holdings in Masimo were worth $1,390,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also recently bought and sold shares of MASI. California Public Employees Retirement System raised its position in shares of Masimo by 21.1% during the 3rd quarter. California Public Employees Retirement System now owns 113,349 shares of the medical equipment provider’s stock worth $16,000,000 after purchasing an additional 19,786 shares during the period. Pathstone Family Office LLC raised its position in shares of Masimo by 91.1% during the 3rd quarter. Pathstone Family Office LLC now owns 6,841 shares of the medical equipment provider’s stock worth $966,000 after purchasing an additional 3,262 shares during the period. Hsbc Holdings PLC raised its position in shares of Masimo by 399.1% during the 3rd quarter. Hsbc Holdings PLC now owns 263,738 shares of the medical equipment provider’s stock worth $37,967,000 after purchasing an additional 210,896 shares during the period. Healthcare of Ontario Pension Plan Trust Fund raised its position in shares of Masimo by 81.2% during the 3rd quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 145,500 shares of the medical equipment provider’s stock worth $20,539,000 after purchasing an additional 65,223 shares during the period. Finally, Blueshift Asset Management LLC acquired a new stake in shares of Masimo during the 3rd quarter worth approximately $525,000. Institutional investors and hedge funds own 87.67% of the company’s stock.

Analysts Set New Price Targets

A number of equities analysts recently issued reports on the company. BTIG Research increased their price objective on Masimo from $195.00 to $200.00 and gave the stock a “buy” rating in a report on Monday, April 17th. Piper Sandler increased their price objective on Masimo from $135.00 to $150.00 and gave the stock a “neutral” rating in a report on Wednesday, March 1st. Raymond James increased their price objective on Masimo from $187.00 to $198.00 and gave the stock an “outperform” rating in a report on Wednesday, March 1st. StockNews.com assumed coverage on Masimo in a report on Thursday, May 18th. They issued a “hold” rating for the company. Finally, Stifel Nicolaus increased their price objective on Masimo from $200.00 to $205.00 in a report on Wednesday, May 10th. Two research analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company’s stock. According to MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus price target of $188.88.

Masimo Stock Performance

Shares of MASI stock opened at $158.51 on Thursday. Masimo Co. has a 1-year low of $108.89 and a 1-year high of $198.00. The company has a current ratio of 2.16, a quick ratio of 1.30 and a debt-to-equity ratio of 0.67. The company has a market capitalization of $8.37 billion, a price-to-earnings ratio of 72.71 and a beta of 0.87. The stock’s fifty day simple moving average is $180.91 and its 200-day simple moving average is $164.03.

Masimo (NASDAQ:MASIGet Rating) last issued its quarterly earnings results on Tuesday, May 9th. The medical equipment provider reported $0.87 earnings per share for the quarter, beating analysts’ consensus estimates of $0.83 by $0.04. Masimo had a return on equity of 19.32% and a net margin of 5.16%. The business had revenue of $565.00 million for the quarter, compared to the consensus estimate of $557.87 million. During the same quarter in the previous year, the company posted $0.93 earnings per share. Masimo’s revenue for the quarter was up 85.7% compared to the same quarter last year. On average, sell-side analysts predict that Masimo Co. will post 4.76 earnings per share for the current fiscal year.

Masimo Company Profile

(Get Rating)

Masimo Corp. is a global technology company, which engages in the development, manufacture, and marketing of patient monitoring technologies, and automation and connectivity solutions. Its products include remote patient monitoring, connectivity, and hospital automation solutions, including Masimo Patient SafetyNet, Masimo Patient SafetyNet Surveillance, Masimo SafetyNet, Masimo SafetyNet-Open, Replica, Iris, MyView, UniView, Uniview: 60, Trace, Masimo Sleep, Centroid, and Bridge.

Recommended Stories

Institutional Ownership by Quarter for Masimo (NASDAQ:MASI)

Receive News & Ratings for Masimo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Masimo and related companies with MarketBeat.com's FREE daily email newsletter.